4//SEC Filing
Colleran David 4
Accession 0001171843-25-001532
CIK 0000898437other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 5:16 PM ET
Size
14.8 KB
Accession
0001171843-25-001532
Insider Transaction Report
Form 4
Colleran David
EVP, General Counsel, Corp Sec
Transactions
- Award
Restricted Stock Unit
2025-03-14+13,669→ 13,669 totalExercise: $0.00→ Common Stock (13,669 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-03-17−6,448→ 12,897 totalExercise: $0.00→ Common Stock (6,448 underlying) - Exercise/Conversion
Common Stock
2025-03-17+6,448→ 49,847 total - Award
Restricted Stock Unit
2025-03-14+28,165→ 28,165 totalExercise: $0.00→ Common Stock (28,165 underlying) - Tax Payment
Common Stock
2025-03-17$15.91/sh−1,893$30,118→ 47,954 total
Footnotes (6)
- [F1]Reflects the first vesting installment of RSUs granted on March 15, 2024, which the Company elected to settle in shares.
- [F2]Reflects an aggregate of 1,893 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2025.
- [F3]Reflects the closing price of ANIK common stock on March 14, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.
- [F4]Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 14, 2026.
- [F5]Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on the vest date. The 13,669 RSUs represent the Target number of shares that may be earned in conjunction with certain market metrics prescribed under the terms of the performance-based phantom RSU award. The award shall cliff vest on the 3rd anniversary of the grant date, subject to the Compensation Committee's determination of achievement of the award prior to the vest date. The number of shares earned and subject to vest, as determined by the Compensation Committee, may be in a range from Threshold (50% of Target) to Maximum (200% of Target). No shares shall vest for achievement under Threshold.
- [F6]Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001646558
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 5:16 PM ET
- Size
- 14.8 KB